CORBETON

This brand name is authorized in Australia, Hong Kong SAR China.

Active ingredients

The drug CORBETON contains one active pharmaceutical ingredient (API):

1	Oxprenolol UNII F4XSI7SNIU - OXPRENOLOL HYDROCHLORIDE
	Oxprenolol is a non-selective, lipophilic betablocker exerting a sympatholytic effect and displaying mild to modest partial agonistic activity (PAA), also known as intrinsic sympathomimetic activity (ISA). Oxprenolol decreases cardiac impulse formation in the sinus node with resultant slowing of the sinus rate.
	Read more about Oxprenolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AA02	Oxprenolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AA Beta blocking agents, non-selective
Discover more medicines within C07AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2961W
HK	Department of Health Drug Office	34684, 34685